Find Academic Supervisors

• Vascular Medicine
• Haemostasis
• Thrombosis
• +3 more

Gordon Lowe is an Honorary Senior Research Fellow at the University of Glasgow's School of Cardiovascular & Metabolic Health. He holds a DSc from Glasgow University (2006) and has been recognized with prestigious awards, including the Kettle Lecture (2006) and the Investigator Award from the International Society of Thrombosis and Haemostasis (2009). His research focuses on vascular diseases (coronary heart disease, stroke, peripheral arterial disease, venous thrombosis) and haemostasis, particularly in relation to haemophilia. He led the Haemostasis and Thrombosis Research Laboratory from 1987, contributing to clinical trials and epidemiological studies on thrombotic and haemorheological factors. Education: MB, ChB (with Honours and gold medal) from the University of St. Andrews (1972). Postgraduate training in internal and vascular medicine at Dundee, Nottingham, and Glasgow. Career highlights include serving as Professor of Vascular Medicine at Glasgow University (1993–2009) and continuing as an Emeritus Professor. Research interests include the interplay between haemostatic factors and cardiovascular outcomes, with over 550 refereed publications. He chairs editorial boards for journals like Journal of Thrombosis and Haemostasis and contributes to clinical guidelines through the Scottish Intercollegiate Guidelines Network (SIGN). Professional roles include past presidency of the British Society for Haemostasis and Thrombosis, and active participation in clinical trial committees. Scientific contributions span meta-analyses of coagulation factors, epidemiological studies on VTE risk, and historical analyses of thrombosis. He is affiliated with the Diabetes, Renal, Endocrine, and Metabolic Medicine Research Theme within his school.

Kyle W. KlarichView profile

Professor

• Structural Heart Disease
• Cardiac Tumors
• Hypertrophic Cardiomyopathy
• +2 more

Kyle W. Klarich is Professor of Medicine and consultant in both the Division of Structural Heart Disease and Division of Echocardiography at Mayo Clinic. His clinical practice and research focus on structural heart disease, cardiac tumors, hypertrophic cardiomyopathies, and valvular heart disease. Dr. Klarich investigates complications prevention and quality-of-life improvement for patients with rare cardiac conditions. As Cardiovascular Disease Fellowship program director since 2010, he is extensively involved in medical education and has received multiple teaching awards including the ACGME's Parker J. Palmer Courage to Teach Award finalist recognition.

• Nephrology
• Diabetology
• Renal Physiology
• +10 more

Ferruh Artunc, MD , is Associate Professor (Apl. Prof.) at the Helmholtz Diabetes Center – Institute for Diabetes Research and Metabolic Diseases (IDM) within the Helmholtz Association in Germany. A board-certified specialist in internal medicine and senior physician, he leads a research group that investigates the pathophysiology of nephrotic syndrome and chronic kidney disease, with special emphasis on proteasuria and sodium retention. Dr. Artunc earned his medical doctorate and completed his habilitation in 2010. In 2014 he was formally conferred the academic title of associate professor. His clinical training and board certification as a specialist in internal medicine were obtained in 2009, and he has served as a senior physician since 2012. Research Interests Mechanisms of proteasuria in nephrotic syndrome Sodium retention and volume regulation in kidney disease Role of serine proteases in renal epithelial sodium channel activation Clinical use of SGLT2 inhibitors in chronic kidney disease and transplant recipients Diuretic resistance and novel therapeutic targets Complications of peritoneal dialysis and pleuroperitoneal leakage Recent work from his laboratory has demonstrated that inhibition of urinary proteases in experimental nephrotic syndrome completely prevents sodium retention without altering proteinuria, opening new avenues for targeted therapy. Scientific Awards Paul Langerhans Prize 2023 – German Diabetes Society Nils Alwall Prize 2019 – German Society for Nephrology Special Award 2018 – Scientific Institute of Nephrology Abstract Prize 2018 – 10th Annual Meeting, German Society of Nephrology Poster Prize 2013 – 5th Annual Meeting, German Society for Nephrology Students & Funding Dr. Artunc actively mentors bachelor’s and master’s students, offering internships and thesis projects. He leads a multidisciplinary team embedded within the German Center for Diabetes Research and collaborates extensively with clinical departments to translate findings into patient care. Laboratory & Affiliations His research group operates within the Helmholtz Diabetes Center and is affiliated with the German Society for Nephrology and the German Society for Internal Medicine. Ongoing projects include prospective clinical trials on SGLT2 inhibitors and mechanistic studies using genetically modified mouse models of nephrotic syndrome.

• Vascular Biology
• Hematology
• Cancer Biology
• +5 more

Dr. Jamie O'Sullivan is a Lecturer and Principal Investigator at the Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland (RCSI). Her research focuses on the bidirectional interactions between coagulation pathways and cancer metastasis, particularly involving von Willebrand Factor (VWF) in diseases like cancer, malaria, and inflammatory conditions. She holds a BSc in Biomedical Science from University College Cork and a PhD in Haematology from Trinity College Dublin, supported by an Irish Research Council scholarship. Notable awards include the 2018 Martin Villar Haemostasis Award and a Novartis Fellowship. Education: PhD in Haematology, Trinity College Dublin (2015) BSc Biomedical Science, University College Cork (Ireland) BSc Biomedical Science, Cork Institute of Technology (Ireland) Research Interests: Her work explores VWF's roles in cancer metastasis, thrombosis, and vascular biology. Key areas include VWF clearance pathways, endothelial-tumor interactions, and therapeutic targeting of VWF in diseases like multiple myeloma and breast cancer. Grants & Funding: Her lab is supported by grants from Science Foundation Ireland, the Irish Research Council, and industry collaborations. Ongoing projects include studies on the VWF-ADAMTS13 axis in cancer-associated thrombosis and the role of tinzaparin in breast cancer metastasis. Awards: 2018 Martin Villar Haemostasis Award Novartis Fellowship (2017–2019) Labs & Teams: The O'Sullivan Lab is part of the Irish Centre for Vascular Biology, collaborating with international groups like KU Leuven University. She also leads the StAR Programme in RCSI, training future researchers in vascular biology.

Annie CurtisView profile

Associate Professor

• Immunology
• Chronobiology
• Inflammation
• +4 more

Prof Annie Curtis is an Associate Professor at the School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland (RCSI). She leads the Curtis Clock Lab, focusing on circadian rhythms' impact on immunity and inflammation. Her research bridges chronobiology with immunology, investigating how molecular clocks regulate innate immune function, particularly in macrophages and dendritic cells. Education: B.A. in Genetics, Trinity College Dublin (1998) PhD in Cardiovascular Pharmacology, University of Pennsylvania (2005) Postgraduate Diploma in Health Professions Education, RCSI (2018) Research Interests: Circadian control of immunity, inflammation, and metabolism. Key areas include: Chronopharmacology for inflammatory disease treatment timing Clock regulation of macrophage and dendritic cell function Interplay between circadian rhythms and metabolic reprogramming in immunity Grants & Funding: EU Horizon 2020/2023: METABOLATE project SFI Career Development Award (2017) SFI Frontiers Award (2021) ChronoVac: Circadian clock-enhanced vaccine efficacy (2021-2025) Awards: L'Oréal-UNESCO Women in Science Fellowship (2017) Roche Medal - Trinity Biomedical Science Institute (2012) ATVB Junior Investigator Award (2006) Lab & Collaborations: Principal Investigator in RCSI's Tissue Engineering Research Group (TERG), and funded investigator in AMBER and FutureNeuro2 centres. Active in science communication through media appearances.

Bryan Michael TuckerView profile

Associate Professor

• Nephrology
• Electrolyte disorders
• Dysnatremia
• +3 more

Bryan Michael Tucker, D.O., M.S., FASN is an Associate Professor in the Department of Medicine at Baylor College of Medicine, specializing in Nephrology. He holds board certifications in Internal Medicine and Nephrology from the American Board of Internal Medicine. His clinical and research expertise focuses on dysnatremia, acid-base disorders, and electrolyte imbalances. Education: Bachelor of Science (BS), California State University, Fullerton (2007) Master of Science (MS), Columbia University (2010) Doctor of Osteopathic Medicine (DO), Western University of Health Sciences (2012) Internal Medicine Residency, Indiana University School of Medicine (2015) Nephrology Fellowship, Yale University School of Medicine (2017) Research Interests: His work addresses critical electrolyte disturbances, including hyponatremia, hypernatremia, and acid-base imbalances in clinical settings. He investigates diagnostic approaches for electrolyte disorders and their impact on patient outcomes in renal care. Recent studies focus on uric acid metabolism in end-stage kidney disease and muscle wasting in diabetes mellitus. Publications: Dr. Tucker has authored over 20 peer-reviewed articles, with contributions to high-impact journals like JAMA and the Journal of the American Society of Nephrology. His articles emphasize practical clinical guidelines for managing electrolyte disorders and improving hemodialysis protocols. Notable areas include urinary magnesium analysis for hypomagnesemia, hypercoagulability in vasculitis, and outcomes associated with hypernatremia in hospitalized patients. Languages: Spanish, Portuguese

• Hematology
• Hemostasis
• Platelet Biology
• +3 more

Henry Rinder, MD, is Professor of Laboratory Medicine and Medicine (Hematology) at Yale School of Medicine, where he serves as Vice Chair for Clinical Affairs in Laboratory Medicine, Director of the Clinical Hematology Laboratory, and Associate Director of the Yale Pathology Residency Program. His clinical work focuses on bleeding/clotting disorders, anemias, and hematologic complications of systemic diseases. Dr. Rinder received his medical degree from the University of Vermont (1984), completed residency at Maine Medical Center (1987-1988), and conducted hematology/clinical pathology fellowships at Yale (1990-1992). He is board-certified in both Clinical Pathology and Internal Medicine. His research examines cell-based diagnostics in hemostasis and inflammation, with specific focus areas including: Platelet dysfunction mechanisms during extracorporeal circulation Metabolic changes in stored platelets Hypercoagulability in substance abuse Reticulated platelets as kinetic biomarkers Complement activation in transfusion reactions Murine models of platelet activation Recent publications (2019-2025) demonstrate strong focus on transfusion medicine innovations, coagulation disorder diagnostics, hematologic malignancy monitoring, and apheresis applications. Collaborative work frequently integrates molecular diagnostics, flow cytometry, and genomic approaches to hematologic investigation. Major honors include: ASCP Mastership Award (2024) Past President, Academy of Clinical Laboratory Physicians & Scientists (2016) Michele D. Raible Lectureship, ASCP (2015) ASCP President's Award (2013) Dr. Rinder leads the Clinical Hematology Laboratory at Yale-New Haven Hospital, overseeing diagnostic services and translational research. He co-authored the 4th/5th editions of Hematology in Clinical Practice and chairs the ASCP Commission on Continuing Professional Development.

• Haematology
• Trauma Coagulopathy
• Endothelial Pathophysiology
• +3 more

Dr. Nicola Curry is an Associate Professor of Haematology and MRC Clinical Academic Research Partnership Fellow at the University of Oxford. She is also a Consultant Haematologist specializing in bleeding and clotting disorders, with a focus on inherited fibrinogen disorders and care for women with bleeding conditions. Her research explores endothelial regulation in trauma coagulopathy, aiming to improve treatments for major hemorrhage. She holds leadership roles in the UKHCDO Girls and Women with Bleeding Disorders Working Party, the ISTH SSC Fibrinogen and FXIII group, and the British Society for Haemostasis and Thrombosis. She trained in medicine at the University of Cambridge, completed clinical and haematology training in London and Oxford, and earned her MD under Prof. Simon Stanworth at NHS Blood & Transplant, Oxford. Her research interests include trauma coagulopathy pathophysiology, endothelial dysfunction, and thrombosis. Recent work focuses on machine learning in diagnostic imaging and clinical trials like the CRYOSTAT-2 study on cryoprecipitate use in trauma hemorrhage. Key publications address trauma management guidelines, thrombosis diagnostics, and transfusion strategies. She actively contributes to national and international committees shaping clinical practice and research. Her clinical practice integrates advanced haemostasis management with a focus on personalized care for complex bleeding disorders.

• Vascular Surgery
• Trauma Surgery
• Endovascular Surgery
• +4 more

Charles J. Fox, MD, serves as a Professor in the Department of Surgery at the University of Maryland School of Medicine, specializing in vascular and trauma surgery with a research focus on hemorrhage control and vascular trauma care. He contributes to the academic community as a reviewer for the Journal of Vascular Surgery and sits on the editorial boards of the Journal of Trauma and Acute Care Surgery and the Journal of Endovascular Trauma Management. Dr. Fox's educational journey includes a BA from the University of Maryland Baltimore County, an MD from George Washington University, surgical residency at Walter Reed Army Medical Center, and vascular surgery fellowship at the same institution. He maintains board certification through the American Board of Surgery. His research centers on REBOA (Resuscitative Endovascular Balloon Occlusion of the Aorta), vascular trauma management, and resuscitation techniques, informed by his extensive military career as a retired U.S. Army Lieutenant Colonel with deployments to Iraq and Afghanistan. This unique perspective bridges battlefield and civilian trauma care, emphasizing hemorrhage control innovations and critical limb ischemia solutions. Analysis of his 15 recent publications (2019-2020) reveals a dominant trend in REBOA optimization, trauma registry analytics, and endovascular protocol standardization. His work spans military-civilian translational research, with studies on pelvic hemorrhage control, celiac artery injuries, and dialysis access complications, demonstrating consistent focus on improving trauma outcomes through evidence-based vascular interventions. Dr. Fox has received notable recognition including: Top Doctor in Vascular Surgery by 5280 magazine (2017-2019) Bronze Star Medal for combat service in Iraq and Afghanistan His grant portfolio demonstrates significant leadership in vascular trauma research: Active DOD grant (W81XWH2010205, $1M) as CO-PI studying REBOA/TXA effects on dysregulated fibrinolysis in polytrauma (5% effort) Multiple completed clinical trials as PI: Critical Limb Ischemia study ($56,773), Humacyte vessel trials for renal disease ($337,370) and trauma ($59,181), and Emergent Truncal Hemorrhage Control study ($334,780) These projects reflect his commitment to advancing hemorrhage control through rigorous clinical investigation. Dr. Fox actively collaborates with national trauma registries including the AAST AORTA registry, develops standardized protocols like the Denver Health REBOA protocol, and leads multi-institutional studies that integrate military-civilian expertise to transform vascular trauma care systems.

Chad J. ZackView profile

Assistant Professor

• Interventional Cardiology
• Cardiovascular Disease
• Blood Clot Lysis
• +6 more

Chad J. Zack, MD is an Assistant Professor in the Department of Medicine, Division of Cardiology at Penn State College of Medicine and serves as Program Director for the Interventional Cardiology Fellowship at Penn State Heart and Vascular Institute. With expertise in interventional cardiology, Dr. Zack specializes in complex coronary interventions, structural heart disease, and vascular procedures. Dr. Zack's research focuses on several key areas in cardiology: Interventional Cardiology techniques and innovations Blood Clot Lysis and Deep Vein Thrombosis management Catheter-directed Thrombolysis procedures Paravalvular Leak interventions Hospital Mortality and outcome analysis Anticoagulation strategies Sex Differences in cardiovascular disease presentation and treatment Dr. Zack's publication record shows consistent scholarly activity with 42 research outputs spanning from 2014 to 2025. His recent work demonstrates particular focus on medical device safety, innovative interventional techniques, and management of complex cardiac conditions. The trend in his publications reflects a growing emphasis on refining interventional approaches while improving patient safety and outcomes. Dr. Zack has received significant scholarly attention for his work, with a h-index of 16 and 1,779 citations according to Scopus data. His research has been particularly influential in the areas of catheter-based interventions and management of complex cardiac conditions. As Program Director for the Interventional Cardiology Fellowship, Dr. Zack plays a key role in training the next generation of interventional cardiologists. His educational background includes medical training at Temple University School of Medicine (2010), residency in Internal Medicine at Temple University Hospital (2013), followed by fellowships in Cardiovascular Disease at Mayo Clinic (2017) and Interventional Cardiology at Duke University (2018).

• Amyotrophic Lateral Sclerosis
• Motor Neuron Disease
• Health Care Economics
• +4 more

Babar Khokhar is an Associate Professor Adjunct in the Department of Neurology at Yale School of Medicine, with significant involvement in the ALS Program and Neurophysiology divisions. His academic journey includes dual degrees from Tufts University (MD and MBA) and a BA in Neuroscience and Economics from Johns Hopkins University. Dr. Khokhar completed his clinical training at Yale-New Haven Hospital, serving as Chief Resident in 2011, followed by a Neuromuscular Medicine Fellowship at the Veterans Administration/Yale School of Medicine in 2012. Dr. Khokhar's educational background includes: BA in Neuroscience and Economics, Johns Hopkins University (2003) MBA, Tufts University (2007) MD, Tufts University School of Medicine (2007) Intern, Yale-New Haven Hospital (2008) Resident, Yale-New Haven Hospital (2010) Chief Resident (Administrative), Yale-New Haven Hospital (2011) Neuromuscular Medicine Fellow, Veterans Administration/Yale School of Medicine (2012) Dr. Khokhar's research spans multiple critical areas in neurology and healthcare systems. His primary focus includes Amyotrophic Lateral Sclerosis (ALS) and Motor Neuron Disease, where he investigates treatment approaches and patient experiences. He also has significant expertise in healthcare economics, services administration, and medical education. His work in health care quality, access, and evaluation addresses systemic challenges in neurological care delivery. Dr. Khokhar's interdisciplinary approach combines clinical neurology with business administration insights from his MBA, allowing him to bridge clinical practice with healthcare management. Analysis of Dr. Khokhar's recent publications reveals a strong focus on healthcare system optimization, particularly in neurological care. His work spans telemedicine implementation, patient flow optimization, and healthcare access improvement. A significant portion of his research addresses ALS and neuromuscular disorders, with recent studies examining patient experiences with methylcobalamin injections. His scholarly contributions also include important work on pandemic response, particularly regarding COVID-19 screening protocols in medical settings. The interdisciplinary nature of his research connects clinical neurology with healthcare administration and policy. Dr. Khokhar has received notable recognition for his contributions to medicine: Humanitarian of the Year (2015) from the Muscular Dystrophy Association Resident of the Year (2011) from Yale School of Medicine Dr. Khokhar maintains active collaborations with colleagues across departments, particularly with Dinesh Pashankar, Anita Arora, Bhaskar Roy, Erica Spatz, and Renee Fekieta. His work on healthcare system improvements likely involves significant grant funding given the scope of implementation studies across large academic health systems. Dr. Khokhar's dual expertise in clinical neurology and healthcare administration positions him well to secure funding for interdisciplinary projects addressing systemic healthcare challenges. Dr. Khokhar is actively involved with Yale's Neurology Department, particularly in the ALS Program and Neuromuscular Medicine division. His work with the Veterans Administration suggests collaboration with the VA Connecticut Healthcare System. While specific laboratory details aren't provided, his research on ALS and patient care systems indicates involvement in both clinical research teams and healthcare operations improvement initiatives. His focus on telemedicine and electronic consultation programs suggests leadership in digital health innovation within the Yale neurology department.

Benjamin BrainardView profile

Professor

• Coagulation
• Platelet Function
• Hypercoagulability in Critical Care Patients
• +3 more

Benjamin Brainard is a Professor and Gunst Professor in Small Animal Medicine at the College of Veterinary Medicine, serving as Director of Clinical Research and affiliated with the Veterinary Teaching Hospital. He holds roles in the Small Animal Medicine & Surgery department and the Office of Research & Faculty and Graduate Affairs. His expertise spans clinical translational research, with a focus on coagulation, fish anesthesia, and small animal critical care. Dr. Brainard earned his VMD from the University of Pennsylvania School of Veterinary Medicine in 2000, followed by an internship in Small Animal Medicine and Surgery at the University of Georgia. He completed dual residencies in Veterinary Anesthesiology and Emergency and Critical Care at the University of Pennsylvania, becoming board-certified in both fields. He serves as an associate editor for the Journal of Veterinary Emergency and Critical Care . His research interests include coagulation defects in critical care, platelet function, hypercoagulability diagnosis, fish anesthesia techniques, and long-term ventilation strategies for small animals. His work has advanced understanding of hemostatic agents, antiplatelet drug effects, and diagnostic methodologies in veterinary medicine. Dr. Brainard leads clinical research initiatives and has contributed to evidence-based guidelines for veterinary CPR through the RECOVER collaborative. His laboratory research focuses on coagulopathy management in dogs and horses, with studies on thrombelastography and platelet function analysis. He actively engages in translational research to bridge clinical practice and scientific discovery. He oversees clinical research operations, mentors trainees, and collaborates on studies involving coagulation disorders, anesthetic protocols, and critical care advancements. His contributions have enhanced diagnostic accuracy and treatment strategies in veterinary emergency medicine.

• Spine Surgery
• Minimally Invasive Surgery
• Adult Spinal Deformity
• +3 more

Raymond Hah, M.D. is an Associate Professor of Clinical Orthopaedic Surgery at the Keck School of Medicine of the University of Southern California (USC), specializing in spine surgery. He practices at the Keck Medical Center of USC and has hospital affiliations with Keck Hospital of USC, USC Norris Cancer Hospital, and USC Verdugo Hills Hospital. Dr. Hah maintains clinical offices in Los Angeles at the Spine Center and in Glendale. Dr. Hah received his medical degree from Northwestern University, completed his residency at LAC+USC Medical Center, and pursued a fellowship in spine surgery at the University of Wisconsin-Madison. He is fluent in English, Spanish, and Korean, which enhances his ability to serve diverse patient populations. Dr. Hah specializes in the management of patients with neck and back disorders, with particular expertise in minimally invasive surgery, adult spinal deformity, and complex spinal reconstruction. His clinical philosophy centers on patient education, ensuring patients are equipped to make informed decisions about their health. He advocates for a multi-disciplinary and multi-modal approach to treatment, believing this offers the best chance for sustained success. When surgery is necessary, Dr. Hah is committed to utilizing cutting-edge technology and techniques to maximize patient experience and outcomes. Dr. Hah's extensive research portfolio demonstrates a strong emphasis on comparative effectiveness research, surgical complications, and innovative approaches to spinal conditions. His work spans cervical, thoracic, and lumbar spine pathologies with particular attention to fusion techniques, deformity correction, and outcomes analysis. Recent publications reveal methodological rigor through large-scale database analyses, systematic reviews, and meta-analyses examining risk factors, surgical approaches, and patient outcomes across diverse spinal conditions. Dr. Hah has received numerous professional recognitions including: NASS: Spineline 20 Under 40 (2021) AAOS: Best Poster Spine Section for "A Nationwide Analysis of Geriatric Odontoid Fracture Incidence, Complications" (2021) Los Angeles Magazine: Southern California Rising Star (2017-2022) Pasadena Magazine: Top Doctor (2016-2021) As an academic physician, Dr. Hah is actively engaged in teaching medical students, residents, and fellows at Keck Medical Center of USC. He serves as a Career Advisor for Orthopaedic Surgery and is an active member of several professional organizations including the North American Spine Society, Lumbar Spine Research Society, AO Spine, and American Academy of Orthopaedic Surgeons. His dedication to clinical research aims to advance the field of spine surgery and improve patient outcomes through evidence-based practice. Dr. Hah's clinical practice encompasses comprehensive spine care, from conservative management to complex surgical reconstruction. He maintains active research programs investigating various aspects of spinal disorders and surgical outcomes, contributing significantly to the academic discourse in orthopaedic spine surgery.

• Haematology
• Thrombosis
• Haemostasis
• +7 more

Murray Adams is an Associate Professor in Haematology at the School of Medical, Molecular and Forensic Sciences, Murdoch University. His work bridges cardiovascular medicine, haematology, and cell biology with a focus on thrombosis and haemostasis. BSc in Medical Science, Curtin University (1992) BSc (Honours) in Medical Science, Curtin University (1993) PhD in Biomedical Science, Curtin University (1999) Research interests center on platelet interactions in antiphospholipid syndrome, thrombosis, and haemostasis. Projects explore how travel, exercise, and blood flow restriction training influence blood coagulation, with a focus on tissue factor pathway abnormalities and biomarker discovery. Key article themes include platelet biology, thrombosis mechanisms, and exercise-induced hemostatic changes. His work spans clinical studies (e.g., compression socks in athletes), molecular investigations (e.g., TRPV1 channels), and autoimmune disease research. Current affiliations include Murdoch University and the Australasian Society of Thrombosis and Haemostasis. He has received grants such as the Clifford Craig Medical Trust Grants (2007) and Lupus research funding ($10,000, 2007).

Victoria EleyView profile

Professor

• Obstetric Anaesthesia
• Maternal Obesity
• Perioperative Care
• +5 more

Professor Victoria Eley is the Mayne Professor and Head of the Mayne Academy of Critical Care at The University of Queensland's Medical School. She holds a medical degree from the University of Tasmania (1999) and a PhD from UQ (2017). Her roles include advancing critical care education and research, alongside clinical anaesthesia services at the Royal Brisbane and Women’s Hospital (RBWH). Her research focuses on optimizing anaesthesia care for obese patients in obstetric and non-obstetric settings, perioperative antibiotic prophylaxis, and blood pressure management. Key areas include maternal obesity's impact on anaesthesia outcomes, surgical site infections, and perioperative microbiome studies funded by Metro North Health. Publications highlight studies on lidocaine dosing, tranexamic acid pharmacokinetics, and antenatal care practices post-bariatric surgery. Grants include projects on anaesthesia reversal agents, perioperative antibiotics and neonatal microbiome links, and thromboelastometry in obstetrics. She supervises PhD candidates in anaesthesia and critical care, including work on obesity-related surgical outcomes and delirium management. Her teaching oversees critical care curricula for UQ medical students, emphasizing evidence-based practice.